Table 2.

Peripapillary vessel density and perfusion density in controls, eyes with superior glaucomatous visual field defects, and fellow eyes at 3 mm and 6 mm circle scan

Vessel density	Control eyes (n=24) A	Fellow eyes (n=17) B	Superior nasal step (n=6) C	Superior arcuate (n=11) D	P A v/s B	P A v/s C	P A v/s D	P B v/s C	P B v/s D
3 mm circle
Superior	18.27±1.85	17.19±2.30	16.36±1.70	15.42±2.13	0.22	0.10	0.002	0.93	0.03
Temporal	17.16±2.86	14.48±4.13	13.34±4.83	13.02±2.55	0.03	0.20	0.01	1	1
Inferior	17.83±2.19	14.23±2.76	14.34±1.73	10.91±2.45	0.006	0.03	0.001	1	0.01
Nasal	17.94±2.22	15.82±1.87	15.98±1.01	14.74±2.39	0.003	0.14	0.001	1	1
Average vessel density	17.56±1.83	15.50±1.97	14.94±1.43	13.87±1.32	0.003	0.03	0.001	1	0.14
6 mm circle
Superior	18.11±1.43	18.21±1.62	17.45±1.38	18.02±1.45	1	1	0.69	0.9	0.66
Temporal	18.53±1.63	17.72±2.63	18.02±1.22	18.37±1.53	0.27	0.95	1	1	1
Inferior	18.42±1.59	16.98±1.69	16.58±1.24	15.70±2.33	0.04	0.04	0.003	0.24	0.02
Nasal	17.46±2.31	17.22±1.77	16.92±2.13	16.63±2.86	1	0.17	0.85	0.50	1
Average vessel density	18.10±1.29	17.82±1.26	17.12±0.81	17.03±1.05	0.80	0.17	0.02	0.68	0.25
Perfusion density
3 mm circle
Superior	.474±.064	.429±.065	.393±.033	.335±.068	0.09	0.03	0.01	0.63	0.04
Temporal	.401±.057	.325±.089	.268±.080	.303±.054	0.003	0.001	0.04	0.43	1
Inferior	.449±.065	.383±.065	.344±.046	.293±.062	0.01	0.008	0.001	0.60	0.03
Nasal	.465±.058	.398±.058	.385±.044	.374±.065	0.001	0.03	0.001	1	1
6 mm circle
Superior	.468±.047	.458±.039	.448±.029	.450±.034	0.68	0.45	0.33	1	1
Temporal	.454±.045	.421±.048	.422±.065	.323±.014	0.31	0.22	1	1	0.28
Inferior	.476±.045	.422±.049	.413±.033	.404±.064	0.03	0.02	0.008	0.44	0.04
Nasal	.447±.068	.431±.052	.399±.056	.423±.076	0.31	0.08	0.67	0.68	1

P<0.05 is significant